Summary
Chevron Corporation (CVX) filed an 8-K on October 3, 2012, to report a change in its Board of Directors and related executive compensation. The primary focus of this filing is the election of Dr. Alice P. Gast to the Board of Directors, effective December 1, 2012. Dr. Gast has also been appointed to the Audit Committee, a key oversight body for financial reporting and internal controls. In conjunction with her appointment, Dr. Gast will receive a prorated grant of restricted stock units (RSUs) and an annual cash retainer, both typical compensation components for non-employee directors. The RSU grant value is tied to the current equity retainer and the company's stock price on her effective date, with vesting scheduled before the 2013 annual meeting. Investors should note this as a routine board refreshment and compensation adjustment rather than a significant strategic or financial event.
Key Highlights
- 1Dr. Alice P. Gast was elected to Chevron's Board of Directors, effective December 1, 2012.
- 2Dr. Gast has been appointed as a member of the Audit Committee of the Board.
- 3The company approved a prorated grant of restricted stock units (RSUs) for Dr. Gast.
- 4The RSU grant's value is determined by the current equity retainer ($184,000) and Chevron's common stock price.
- 5Dr. Gast will receive a prorated annual cash retainer as a non-employee director.
- 6The effective date of Dr. Gast's appointment to the board is December 1, 2012.